Rifampicin - from tuberculosis to psoriasis?

Nissen, Lisa M. (2011) Rifampicin - from tuberculosis to psoriasis?. Australian Pharmacist, 30 5: 372-373.

Attached Files (Some files may be inaccessible until you login with your UQ eSpace credentials)
Name Description MIMEType Size Downloads
AustPharm_Rifampicin.pdf AustPharm_Rifampicin.pdf application/pdf 588.91KB 55
Author Nissen, Lisa M.
Title Rifampicin - from tuberculosis to psoriasis?
Journal name Australian Pharmacist   Check publisher's open access policy
ISSN 0728-4632
Publication date 2011-05
Sub-type Article (original research)
Open Access Status File (Author Post-print)
Volume 30
Issue 5
Start page 372
End page 373
Total pages 2
Place of publication Australia
Publisher Pharmaceutical Society of Australia
Collection year 2012
Language eng
Abstract The use of rifampicin, a bactericidal antibiotic drug commonly used to treat tuberculosis, in the management of psoriasis is examined. Studies show that doses of 300-600mg per day of rifampicin, in combination with other treatments and over varying periods of time, can improve symptoms in some patients with psoriasis.
Q-Index Code CX
Q-Index Status Confirmed Code
Institutional Status UQ
Additional Notes old drug new indication

Document type: Journal Article
Sub-type: Article (original research)
Collections: Non HERDC
School of Pharmacy Publications
Version Filter Type
Citation counts: Google Scholar Search Google Scholar
Created: Thu, 29 Sep 2011, 11:07:19 EST by Charna Kovacevic on behalf of School of Pharmacy